News Breaks |
|
|
| February 28, 2013 |
| 05:55 EDT |  | MDT, MDT, COV, COV, INTC, INTC, BSX, BSX, VRTX, VRTX, JNJ, JNJ | Opal to host a summit
4th Annual Medical Devices Summit is being held in Boston on February 28-March 1. |
|
|
News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days Check below for free stories on MDT;COV;INTC;BSX;VRTX;JNJ the last two weeks. |
|
|
| May 16, 2013 |
| 07:28 EDT | | BSX, COV | I/O Central to host a conference
 Subscribe for More Information |
|
| 06:32 EDT |  | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| 05:59 EDT |  | INTC | High tech firms involved in immigration battle, WSJ reports
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT |  | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| May 14, 2013 |
| 15:33 EDT | | BSX | Boston Scientific has a conference call hosted by JPMorgan
JPMorgan Analyst Weinstein will host a conference call with CEO Mike Mahoney on May 17 at 11 am. |
|
| May 13, 2013 |
| 07:30 EDT | | INTC | TechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
|
| May 10, 2013 |
| 15:49 EDT | | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
|
| 14:02 EDT |  | VRTX | Vertex to benefit from Welsh government decision, says Wells Fargo
Subscribe for More Information |
|
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 10:00 EDT |  | BSX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
| |
| 09:03 EDT | | BSX | Boston Scientific receives CEO Mark approval for Rhythmia mapping system
Subscribe for More Information |
|
| 06:16 EDT | | COV, JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| 05:46 EDT | | BSX | Boston Scientific upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT | | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 14:30 EDT |  | INTC | Options Update; May 9, 2013
Subscribe for More Information |
|
| 12:04 EDT | | BSX | Boston Scientific says data show Watchman device superior to warfarin
Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrated the WATCHMAN Left Atrial Appendage Closure device was statistically superior to warfarin for preventing cardiovascular death, all-cause stroke and systemic embolization. The data demonstrated significant reductions in both cardiovascular and all death compared to warfarin. The data were presented today as a late-breaking clinical trial at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions. |
|
| 09:51 EDT | | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
|
| 09:27 EDT | | BSX | Leerink's medical devices analyst holds a conference call
Subscribe for More Information |
|
|
|
|
|
